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Direct Hematopoietic Cell Fates
Toll-like receptors (TLRs) modulate immune re-
sponses indirectly by promoting the efficacy of anti-
gen presentation. In this issue of Immunity, Nagai
et al. (2006) demonstrate that TLR signals also bias
hematopoietic progenitor cells toward myelopoiesis
directly by replacing cytokine and differentiative cues.
Hematopoietic progenitor cells produce the leukocytes
of both the innate and the adaptive immune systems.
The common ancestor of all these cells, the hematopoi-
etic stem cell (HSC), has the capacity for self-renewal
and the ability to produce by asymmetric division more
differentiated, nonrenewing multipotent progenitors
(MPPs). Progeny of the MPPs subsequently lose devel-
opmental plasticity to establish committed lineages of
progenitor cells known as common lymphoid progeni-
tors (CLPs) and common myeloid progenitors (CMPs).
CLPs generate all classes of lymphocytes, and CMPs
produce granulocytes, monocytes, erythrocytes, and
megakaryocytes. Whereas the lymphoid and myeloid
differentiation pathways are generally thought to be
mutually exclusive, there is evidence for alternative, bi-
potent pathways, and, curiously enough, both CLP and
CMP appear able to generate dendritic cells (DCs) (Kon-
do et al., 2003) (Figure 1).
Normally, this leukopoiesis is thought to take place in
specialized bone marrow microenvironments known as
stem cell niches (Wilson and Trumpp, 2006). These
niches protect HSCs—and perhaps their more differen-
tiated progeny—from environmental perturbations that
might activate quiescent cell pools or affect develop-
mental fate decisions. HSC niches shelter stem cells
from the sturm und drang of the peripheral lymphoid tis-
sues and provide relief from exogenous signals that
might interfere with the normal cell differentiation plan.
How very surprising it is then, that Yoshinori Nagai
and his colleagues (Nagai et al., 2006) show in this issue
of Immunity that the source of virtually all immunologi-
cal storm and stress, Toll-like receptors (TLRs), are ex-
pressed on HSCs and their progeny, especially CLP and
granulocyte/macrophage progenitors (GMPs).
TLRs interact with specific microbial components and
are abundantly expressed on many mature leukocytes,
including macrophages and DCs, B lymphocytes, and
some T cell subsets. TLRs are expressed on the cell sur-
face or within endosomal compartments; TLR ectodo-
mains comprise multiple leucine-rich repeats that bind
microbial protein, carbohydrate, or nucleic acid struc-
tures, and the intracytoplasmic domains bear a charac-
teristic Toll IL-1 receptor resistance (TIR) signaling motif
(Akira et al., 2006). TLR genes are present in fish, amphib-
ians, and birds, and mammals express ten to twelve
TLRs that can be organized into six families that are also
represented in lower vertebrates; indeed, theDrosophila
Toll9 gene is sufficiently similar to mammalian TLR genesto indicate an evolutionary origin that predates the
divergence of insects and vertebrates (Beutler, 2005).
TLR ligands induce receptor dimerization and confor-
mational changes that recruit adaptor molecules to the
cytoplasmic TIR domain. Four adaptors are currently
known: MyD88, TIRAP (Mal), TRIF (TICAM1), and TRAM.
MyD88 is critical for TLR signaling, and it recruits the
secondary kinases, IL-1R-associated kinase 4 (IRAK-4)
and IRAK-1, to the TIR motif. TIRAP is required for
recruiting MyD88 to activated TLR4, and this MyD88
TIRAP signal pathway leads to the expression of proin-
flammatory cytokines. TRAM-TRIF signaling is distinct
from the MyD88 pathway and elicits IFN-b and IFN-
inducible gene expression (Akira et al., 2006).
It can scarcely have escaped anyone’s attention that
TLR signaling initiates acute inflammatory responses by
induction of inflammatory cytokines and chemokines. In
addition, TLR signaling is an important component of
DC maturation and activation; without TLR signaling,
DCs are unable to function as effective antigen-present-
ing cells (APCs) for naive T helper cells. Activated DCs
also release inflammatory cytokines that mitigate sup-
pression by T regulatory cells. More recently, TLR sig-
naling in B cells was reported to be necessary for the
maintenance of serum IgM and IgG amounts as well
as for the induction of IgG1 and IgG2 antibody by T-
dependent antigens (Pasare and Medzhitov, 2003). This
claim is, however, the subject of vigorous debate (Nem-
azee et al., 2006; Pasare and Medzhitov, 2006).
It is within this inflammatory context that the findings
of Nagai et al. (2006) are so remarkable. Populations of
HSCs, MPPs, and more differentiated progenitors ex-
press TLR2 and/or TLR4 and their associated accessory
molecules. In vitro, LPS and Pam3CSK4, ligands for
TLR4 and TLR2, respectively, drove normal but not
MyD88-deficient HSCs and MPPs to proliferate and
greatly increased their output of differentiated progeny.
Even more remarkably, GMP—and, to a lesser extent,
CMP—cultures containing LPS no longer depended on
the M-CSF and GM-CSF growth and differentiation fac-
tors for cell survival and differentiation. LPS and
Pam3CSK4 promoted CLPs to generate increased num-
bers of CD11c+ DC. In vivo, LPS administered by intra-
venous or intraperitoneal injection quickly found its
way to the bone marrow and modulated the TLR4 re-
ceptor complex on HSCs and MPPs. TLR ligands act
on hematopoietic progenitor cells to bias hematopoie-
sis toward production of monocytes and macrophages
with inflammatory phenotypes (Figure 1).
Nagai et al. (2006) conclude that TLR ligands are cues
for hematopoietic cell proliferation and fate determina-
tion and that this interaction constitutes an innate re-
sponse to microbial pathogens. Leukocyte progenitor
cells are direct sensors of inflammation and respond
accordingly by increasing the production of myeloid
leukocytes to control infection. The links between TLRs
and immunity now extend from the secondary lymphoid
tissues to the sites of primary leukopoiesis.
While surprising, the observations of Nagai et al.
(2006) are not without some precedent. Previously,
Immunity
668Figure 1. Hematopoiesis under Steady-State and Inflammatory Conditions
All hematopoietic lineages arise from a common ancestor, the hematopoietic stem cell (HSC). In turn, the self-renewing HSC gives rise to pro-
genitor cells with more limited developmental plasticity through asymmetric division. Committed myeloid progenitors (CMPs) and committed
lymphoid progenitors (CLPs) are multipotent cells incapable of self-renewal but under normal, steady-state conditions (left) generate all differ-
entiated myeloid and erythroid (CMP) or lymphoid (CLP) cell types. CLPs differentiate to B or T lymphocytes under the influence of IL-7, to NK
cells with IL-15, or to DCs. CMPs produce even more differentiated granulocyte and macrophage progenitors (GMP) that respond to granulocyte
colony stimulating factor (G-CSF) or macrophage colony stimulating factor (M-CSF) by differentiating to granulocytes or macrophages, respec-
tively. Megakaryocyte and erythroid progenitors (MEPs) are driven by thrombopoietin (TPO) or erythropoietin (EPO) to form, respectively, mega-
karyocytes or erythrocytes. In the presence of the TLR ligands LPS and Pam3CSK4 (right), HSCs and more differentiated progenitors bearing
TLR2 and/or TLR4 respond by altering hematopoietic output. GMPs become capable of producing granulocytes and macrophages in the ab-
sence of G-CSF or M-CSF, and while lymphocyte production by CLPs is reduced, DC output becomes increased. Generation of megakaryocytes
and erythrocytes by MEPs is little affected.Yoshihiro Ueda and his colleagues (Ueda et al., 2004,
2005) demonstrated that LPS and various other in-
flammogens profoundly and rapidly affect bone marrow
hematopoiesis by the mobilization of lymphoid progen-
itors to the blood and spleen and the consequent ex-
pansion of central myelopoiesis. These effects could
be mimicked by recombinant TNFa and IL-1b and were
minimized in TNF receptor-deficient mice. Ueda also
observed that this inflammatory redirection of leukopoi-
esis correlated with reductions in bone marrow CXCL12
and stem cell factor amounts and demonstrated that
CMPs were less sensitive to these growth factors than
were CLPs.
Ueda’s observations complement the present work of
Nagai et al. (2006), and together these reports suggest
an intimate and highly regulated link between primaryleukopoiesis and inflammation that acts to expand the
production of granulocytes and monocytes in response
to infection. During infection, acute monocyte and/or
granulocyte responses are crucial for host protection,
and, in contrast to lymphocytes, most mature mono-
cytes and granulocytes are short lived and incapable
of mitosis. TLR signaling in leukocyte progenitors and
the modification of the bone marrow’s generative niches
may represent a natural form of ‘‘just in time manufactur-
ing’’ that maximizes innate responses to microbial path-
ogens while minimizing the deleterious effects and risks
of chronic inflammation. This notion is an attractive pos-
sibility and one that highlights the ancient role of Toll
genes in development (Ferrandon et al., 2004).
The tantalizing possibility that (at least some) TLR li-
gands can replace the endogenous cytokines normally
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of hematopoietic progenitors (Nagai et al., 2006) merits
widespread attention and will surely be the object of
further investigation. Does TLR engagement drive pro-
genitor cell development by a molecular mechanism
that parallels the normal, cytokine-signal pathway(s) or
via some unknown receptor crosstalk? If the latter,
where and how might the signaling pathways of TLR
and growth factor receptors intersect? Given that LPS
and Pam3CSK4 acted as cytokine surrogates only in
MyD88-sufficient cells, a starting point for these ques-
tions is clear, even if the answers are not. Regardless
of how TLRs influence hematopoietic fate decisions,
the possibility that HSCs listen and respond to environ-
mental cues requires a new appraisal of just how innate
immunity and acquired immunity are intertwined.
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Pre-T Cell Receptor’s
clashing Signals:
‘‘Should I Stay or Should I Go’’
In this issue of Immunity, Kersh and colleagues (Xi
et al., 2006) investigate the regulatory network that
permits two otherwise clashing cellular processes—
proliferation and gene rearrangement—to occur at
temporally distinct periods following the formation
of the pre-T cell receptor (pre-TCR) complex.
At a critical time during T cell development, known as
b selection, immature CD42 CD82 double-negative
(DN) thymocytes expressing a pre-T cell receptor (pre-
TCR; a productively rearranged TCR-b paired with
a pre-Ta) receive a set of signals that mediate cellular
survival, proliferation, differentiation to the CD4+ CD8+
double-positive (DP) stage, cessation of TCR-b gene re-
arrangement, and initiation of TCR-a gene rearrange-
ment (von Boehmer and Fehling, 1997). b selection is
driven by the pre-TCR and encompasses the first
checkpoint of T cell development, and, as such, cells
that fail to generate a TCR-b chain do not proceed along
the ab-lineage differentiation pathway. At the center of
b selection lie two incompatible cellular processes,
i.e., induction of proliferation and initiation of gene
rearrangement.
Expression of the pre-TCR triggers a complex differ-
entiation program (Michie and Zu´n˜iga-Pflu¨cker, 2002).
However, the signaling pathways and genetic regulatory
networks that mediate the various aspects of b selectionSelected Reading
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have not been fully elucidated. Among the earliest tran-
scriptional changes induced by pre-TCR signals is the
expression of the zinc finger transcription factor, early
growth response gene-3 (Egr3) (Xi and Kersh, 2004a,
2004b). In previous studies, Kersh and Xi demonstrated
that Egr3 expression is rapidly and transiently induced
in b-selected cells. Using a transgenic overexpression
system, they investigated the effect of sustained ex-
pression of Egr3 past the b selection checkpoint and
noted increased apoptosis of DP cells and altered TCRa
rearrangement. These effects resulting from ectopic
expression of Egr3 in DP thymocytes were due to a
reduced expression of Bcl-xL and the thymic isoform
of the retinoic acid receptor-related orphan receptor-g
(RORgt), which are necessary for DP survival (Sun
et al., 2000). These initial findings begged the question
of whether Egr3 regulates RORgt directly or indirectly.
The answer appears to be yes, as both effects seem
to be in operation (Xi et al., 2006).
In the present work, Kersh and Xi take advantage of
a variety of experimental model systems, including
a DP cell line to examine the function of RORgt expres-
sion in blocking proliferation and to analyze RORgt
promoter regulation by Egr3. They also make use of
ChIP-mediated cloning to uncover a new RORgt
transcriptional target, mCPEB4, an RNA binding protein
that appears to inhibit cell division. Additionally, Egr3-
transgenic mice and Egr3-deficient mice are employed
to demonstrate an inverse correlation between Egr3
and RORgt expression, which they show to be due to
Egr3-induced expression of the E protein inhibitor Id3
that prevents E2A (E12/E47)-dependent RORgt expres-
sion. Of interest, they also report a direct association
